Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · IEX Real-Time Price · USD
7.86
-0.08 (-1.02%)
Mar 28, 2024, 1:31 PM EDT - Market open

Actinium Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2011
Revenue
1.031.1400000000
Upgrade
Revenue Growth (YoY)
-9.97%---------
Upgrade
Gross Profit
1.031.1400000000
Upgrade
Selling, General & Admin
128.086.315.526.739.199.0211.2710.183.48
Upgrade
Research & Development
23.1418.0316.0916.5517.0917.7217.8313.512.273.11
Upgrade
Other Operating Expenses
00000000.050.040.01
Upgrade
Operating Expenses
35.1326.1122.3922.0723.8326.9126.8524.8322.486.59
Upgrade
Operating Income
-34.1-24.96-22.39-22.07-23.83-26.91-26.85-24.83-22.48-6.59
Upgrade
Interest Expense / Income
000000.01-0.010.0100
Upgrade
Other Expense / Income
-1.09-0.19-0.18-0.17-0.17-0.31-2.52-3.812.214.18
Upgrade
Pretax Income
-33.02-24.77-22.22-21.9-23.65-26.6-24.32-21.03-24.69-10.77
Upgrade
Net Income
-33.02-24.77-22.22-21.9-23.65-26.6-24.32-21.03-24.69-10.77
Upgrade
Preferred Dividends
0000000000
Upgrade
Net Income Common
-33.02-24.77-22.22-21.9-23.65-26.6-24.32-21.03-24.69-10.77
Upgrade
Shares Outstanding (Basic)
2421125422111
Upgrade
Shares Outstanding (Diluted)
2421125422111
Upgrade
Shares Change
17.37%69.51%143.87%40.77%58.87%37.73%27.01%39.45%20.27%1961.81%
Upgrade
EPS (Basic)
-1.37-1.20-1.83-4.40-6.60-12.00-15.00-16.50-27.00-14.10
Upgrade
EPS (Diluted)
-1.37-1.20-1.83-4.40-6.60-12.00-15.00-16.50-27.00-14.10
Upgrade
Free Cash Flow
8.28-21-21.87-21.53-20.67-21.58-20.85-18.59-14.5-6.31
Upgrade
Free Cash Flow Per Share
0.34-1.02-1.80-4.33-5.85-9.70-12.91-14.62-15.90-8.32
Upgrade
Gross Margin
100.00%100.00%--------
Upgrade
Operating Margin
-3311.07%-2182.17%--------
Upgrade
Profit Margin
-3205.53%-2165.56%--------
Upgrade
Free Cash Flow Margin
803.69%-1835.58%--------
Upgrade
EBITDA
-32.32-24.25-21.77-21.48-23.6-26.54-24.25-20.96-24.65-10.77
Upgrade
EBITDA Margin
-3137.67%-2119.76%--------
Upgrade
Depreciation & Amortization
0.70.520.450.420.050.060.080.050.040
Upgrade
EBIT
-33.02-24.77-22.22-21.9-23.65-26.6-24.33-21.02-24.69-10.77
Upgrade
EBIT Margin
-3205.53%-2165.56%--------
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).